|
Cancer Biomarkers
ISSN: 1574-0153 Volume 7-8; 12 issues Institutional subscription (print and online) for 2010: €1114 / US$1465 (including postage and handling) Click on the subscribe button for more options, including personal subscription prices. Status Report: Last issue (volume 6:1) online on 17 February 2010 Next issue (volume 6:2) scheduled for March 2010 Aims and Scope Editorial Board Submission of Manuscripts Abstracted in Download flyer for this journal |
|
||||||||||||||||||||||||||||||||
|
Editor-in-Chief Sudhir Srivastava PhD, MPH
c/o IOS Press, Inc. 4502 Rachael Manor Drive Fairfax, VA 22032 USA E-mail: submissions@iospress.com Associate Editors Anna Lokshin PhD
E-mail: lokshina@pitt.edu Attila T. Lorincz PhD E-mail: a.lorincz@qmul.ac.uk Paola Muti MD E-mail: pmuti@hsph.harvard.edu Harvey Pass MD E-mail: harvey.pass@nyumc.org Statistical Editors S. Baker
Rockville, MD, USA Z. Feng Seattle, WA, USA M. Pepe Seattle, WA, USA S. Skates Boston, MA, USA Editorial Board
See instructions to authors. Concentrating on molecular biomarkers in cancer research, Cancer Biomarkers publishes original research findings (and reviews solicited by the editor) on the subject of the identification of markers associated with the disease processes whether or not they are an integral part of the pathological lesion. The disease markers may include, but are not limited to, genomic, epigenomic, proteomics, cellular and morphologic, and genetic factors predisposing to the disease or indicating the occurrence of the disease. Manuscripts on these factors or biomarkers, either in altered forms, abnormal concentrations or with abnormal tissue distribution leading to disease causation will be accepted. Abstracted in
CABS database,
EMBIO,
Journal Citation Reports/Science Edition,
Prous Science Integrity,
Pubmed,
PubsHub,
Scopus
Backvolumes
1-6
Conferences
|
|||||||||||||||||||||||||||||||||